Oragenics Inc. Executive Compensation Revealed
Ticker: OGEN · Form: DEF 14A · Filed: Apr 1, 2025 · CIK: 1174940
Sentiment: neutral
Topics: executive-compensation, DEF14A, stock-awards, option-awards
Related Tickers: OGEN
TL;DR
Oragenics exec pay details out for 2024, stock/option awards listed.
AI Summary
Oragenics Inc. filed a DEF 14A on April 1, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on compensation for individuals such as Michael Redmond, a member of the OGEN board, and other non-PEO/NEO members. Specific dollar amounts for stock and option awards are reported for both 2023 and 2024.
Why It Matters
This filing provides transparency into how Oragenics Inc. compensates its top executives, which can influence investor decisions and employee morale.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing disclosing executive compensation, which is standard for public companies and does not inherently indicate new risks.
Key Numbers
- 2024 — Fiscal Year End (Compensation details reported for this year.)
- 2023 — Prior Fiscal Year (Comparative compensation data provided.)
Key Players & Entities
- Oragenics Inc. (company) — Filer of the DEF 14A
- Michael Redmond (person) — Member of OGEN board, compensation reported
- 0001174940 (company) — Central Index Key for Oragenics Inc.
FAQ
What is the total compensation for Michael Redmond in 2024?
The filing indicates that compensation details for Michael Redmond for the fiscal year 2024 are reported, but specific dollar amounts are not provided in this excerpt.
What types of compensation are detailed for Oragenics Inc. executives?
The filing details amounts reported under stock awards and option awards for executives.
When was this DEF 14A filing submitted?
This filing was submitted on April 1, 2025.
What is the primary business of Oragenics Inc. according to the filing?
Oragenics Inc. is classified under Pharmaceutical Preparations (SIC code 2834).
Are compensation details provided for non-PEO/NEO members?
Yes, the filing includes compensation information for 'ecd:NonPeoNeoMember' for the fiscal years 2023 and 2024.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 1, 2025 by Michael Redmond regarding ORAGENICS INC (OGEN).